Director/PDMR Shareholding

Dr. Martens PLC

03 June 2024

 

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial Responsibility

Dr. Martens plc (the "Company") announces that it has been notified of the following transaction in the Company's Ordinary 1p shares undertaken on behalf of a director / person discharging managerial responsibility ("PDMR").

Shortly after joining the Company on 13 May, Giles Wilson, Chief Financial Officer, received a cash payment to compensate him for the loss of bonuses he stood to receive at his previous employer. In line with the Company's Remuneration Policy, one third of the net amount payable was subsequently used to purchase shares which Giles is required to hold for a minimum of two years.

The relevant notification, set out below, is provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Giles Wilson
2	Reason for the notification
a)	Position/status	PDMR (Chief Financial Officer)
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Dr. Martens plc
b)	LEI	213800QPT8YM6NQZPH28
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24
b)	Nature of the transaction	Purchase of Ordinary shares under the Global Bonus Scheme
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.8745 73,145
d)	Aggregated information - Aggregated volume - Price	73,145 £0.8745
e)	Date of the transaction	2024-05-30
f)	Place of the transaction	London Stock Exchange (XLON)

 

END